Domo, Inc.
NASDAQ:DOMOSoftware - Application
+$0.43 today
- Market cap
- $155.39M
- Beta
- 1.77
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$1.28
Volume 3.18M
Average 1.39M
DOMO Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Domo, Inc.NASDAQ: DOMO
Net Receivables · Q1 FY2027 · quarter ended Apr 2026
Net receivables rises 14.9% from a year ago
Net receivables stood at $50.47M at the end of Q1 FY2027, up 14.9% from a year earlier and down 40.9% from the prior quarter. Over 3 fiscal years it compounded at +2.7% a year.
Context
- Net receivables amounted to 25.7% of total assets at the end of Q1 FY2027, up 2.5 pp from a year earlier.
- Net receivables increased in 2 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps rising in the next quarterly balance sheet after a +14.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2026
- 85.46M USD
- Year-over-year change
- +19.4%
- 4-year CAGR
- +7.4%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 85.46M | +19.4% |
| FY2025 | 2025-01-31 | 71.54M | +6.5% |
| FY2024 | 2024-01-31 | 67.2M | -14.9% |
| FY2023 | 2023-01-31 | 78.96M | +23.1% |
| FY2022 | 2022-01-31 | 64.15M | — |
Net Receivables vs competitors
How DOMO compares with its peers on the latest reported figures
- DOMO's Apr 2026 net receivables of $50.47M is the 5th highest of the 11 companies compared; the peer median is $15.17M.
- Its year-over-year change of +14.9% is the 7th highest of 11, against a peer median of +23.8%.
- Net receivables amounts to 25.7% of total assets for DOMO, versus a peer median of 7.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $251.24M | +32.2% | +12.1% | 29.9% | |
| Mar 2026 | $73.77M | -24.8% | +9.0% | 5.0% | |
| Mar 2026 | $69.42M | +7.2% | +41.3% | 13.6% | |
| Mar 2026 | $63.61M | -2.2% | +9.4% | 10.3% | |
| Apr 2026 | $50.47M | +14.9% | +2.7% | 25.7% | |
| Mar 2026 | $16.73M | +1559.4% | +159.1% | 23.6% | |
| Mar 2026 | $13.61M | +15.4% | +5.4% | 2.8% | |
| Mar 2026 | $4.64M | +48.1% | +9.7% | 2.3% | |
| Mar 2026 | $4.26M | +140.7% | +35.7% | 2.2% | |
| Mar 2026 | $3.3M | +84.5% | -26.6% | 9.1% | |
NBPNovaBridge Biosciences | Dec 2025 | $256.33K | -97.0% | -62.4% | 0.7% |
| Peer median (excluding DOMO) | $15.17M | +23.8% | +9.5% | 7.1% | |
Competitors are the stored peer set for DOMO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 83.56M | 66.5M | 60.94M | 45.26M | 42.95M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 64.15M | 78.96M | 67.2M | 71.54M | 85.46M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 15.42M | 23.36M | 9.6M | 24.87M | 25.15M |
| Total Current Assets | 173.1M | 168.81M | 137.74M | 141.68M | 153.56M |
| Property, Plant & Equipment (Net) | 33.98M | 36.63M | 38.75M | 38.78M | 39.96M |
| Goodwill | 9.48M | 9.48M | 9.48M | 9.48M | 9.48M |
| Intangible Assets | 2.88M | 2.79M | 2.74M | 2.13M | 1.56M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 25.16M | 24.4M | 36.96M | 22.28M | 30.98M |
| Total Non-current Assets | 71.49M | 73.3M | 87.92M | 72.66M | 81.98M |
| Total Assets | 244.59M | 242.12M | 225.66M | 214.34M | 235.53M |
| Account Payables | 4.77M | 12.12M | 4.31M | 10.03M | 18.77M |
| Short-term Debt | 3.44M | 4.91M | 4.81M | 10.17M | 7.47M |
| Tax Payables | 8.32M | 3.95M | 3.81M | 3.88M | 0 |
| Deferred Revenue | 168.34M | 182.27M | 185.25M | 178.28M | 174.89M |
| Other Current Liabilities | 15.66M | 19.77M | 21.85M | 30.9M | 70.1M |
| Total Current Liabilities | 236.52M | 248.6M | 237.8M | 254.95M | 271.22M |
| Long-term Debt | 103.99M | 108.61M | 113.53M | 117.67M | 126.49M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 2.42M | 3.61M | 2.74M | 2.83M | 6.02M |
| Other Non-current Liabilities | 10.88M | 12.43M | 14M | 8.45M | 12.18M |
| Total Non-current Liabilities | 134.05M | 139.91M | 141.41M | 136.64M | 150.37M |
| Total Liabilities | 370.57M | 388.52M | 379.21M | 391.59M | 421.6M |
| Common Stock | 33K | 35K | 37K | 39K | 42K |
| Retained Earnings | (1.22B) | (1.33B) | (1.41B) | (1.49B) | (1.55B) |
| Accumulated OCI | 388K | (322K) | (180K) | (669K) | 1.12M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | (125.98M) | (146.4M) | (153.55M) | (177.25M) | (186.06M) |
| Total Debt | 124.18M | 128.78M | 129.48M | 135.53M | 139.64M |
| Net Debt | 40.62M | 62.28M | 68.54M | 90.27M | 96.69M |
Domo, Inc.
NASDAQ:DOMO
Intrinsic Alpha fair value
Locked
Current Price
$3.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.